Growth equity · Paris

Capital for companies that care for life.

We back ambitious healthcare and technology companies across pharmaceuticals, medical devices, software and health data, bringing patient capital, sector expertise and a calm, long-term partnership.

4Focus sectors
€5–40MTypical ticket size
5–7 yrsInvestment horizon
Physician reviewing digital health data on a tablet
Patient, sector-focused capitalMinority & majority growth
What we invest in

Four sectors, one conviction: better health through better companies.

All services
Pharmaceutical growth capitalPharmaceuticals

Pharmaceutical growth capital

Minority and majority growth investments in specialty pharma, CDMOs and consumer health companies that already have commercial traction and need capital to scale manufacturing, registrations and international distribution.

Book a consultation
Medical devices & diagnosticsMedical devices

Medical devices & diagnostics

Capital and hands-on support for MedTech companies with CE-marked or FDA-cleared products, helping them move from early adoption to broad clinical use while meeting MDR and IVDR requirements.

Book a consultation
Healthcare softwareHealth software

Healthcare software

Growth equity for SaaS and digital health platforms serving hospitals, clinics, payers and life sciences companies, with a focus on recurring revenue, clinical integration and product-led expansion.

Book a consultation
Health data & analyticsHealth data

Health data & analytics

Investments in companies that turn real-world evidence, clinical and operational data into better decisions, always grounded in GDPR compliance, data ethics and certified hosting.

Book a consultation
Investment team working with founders
Our approach

A partner at the table, not just on the cap table.

Growth is rarely linear in healthcare. Regulatory milestones, clinical adoption and reimbursement cycles demand investors who understand the terrain. We work alongside founders and management teams with clear priorities and quiet discipline.

  • Shared value-creation plan agreed before closing
  • Access to operating partners, clinicians and regulatory experts
  • Aligned governance that respects founder leadership
Learn about us
Why founders choose us

Thoughtful capital, built around your company.

Sector depth

Investment professionals with backgrounds in pharma, MedTech, clinical practice and health IT.

Regulatory fluency

Practical experience of MDR, IVDR, GDPR, HDS hosting and European market access pathways.

European reach

A network across France, the Nordics, DACH and Benelux to open doors to customers and partners.

Long-term horizon

Holding periods matched to the realities of clinical adoption and product development cycles.

Responsible investing

ESG and patient-impact criteria integrated from first meeting to exit.

Buy-and-build

Support for targeted acquisitions that accelerate geographic and product expansion.

We look for companies whose growth makes care more precise, more accessible and more humane, and we stay patient enough to let that growth compound.
The TECHLIFE CAPITAL investment team

Building the next chapter of your healthcare company?

Share your project with our investment team. We reply to every qualified enquiry within five business days.

Start a conversation